Search
for
Sort by
Research 331–360 of 1000+
- 63418 JAK3/TEC kinase pathways are active in alopecia areata lesions, and their inhibition with Ritlecitinib prevents αCD3/αCD28+IL-2 induced immune privilege collapse in healthy hair follicles ex vivo
- 573 Discovery of JW0061, a novel GFRA1 agonist, as a hair regeneration stimulant via WNT signaling activation in dermal papilla cells
- Urological Oncology: Prostate Cancer
- Cortical cell types and intermediate filament arrangements correlate with fiber curvature in Japanese human hair
- THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Influence of age and of testosterone on the response of male rats to parachlorophenylalanine
- Alopecia: Kids are not just little people
- P‐79 Hair follicle growth arrest in Austrian Icelandic horses
- A rare LMNA missense mutation causing a severe phenotype of mandibuloacral dysplasia type A: a case report
- CONTRACEPTION AND THE SKIN
- Alkaline Phosphatase Reaction in Hair Follicles of Male Beagle Dogs during Hair Cycle Stages*
- Pre-/postbiopsy diagnosis concordance in women from an Afro-Caribbean population: Response to Douglas et al “Scalp biopsy influences diagnostic accuracy and treatment in Black women with alopecia: A retrospective study”
- HAIR BANDS IN FACIO‐GENITO‐POPLITEAL SYNDROME
- JAK inhibitors in dermatology: The promise of a new drug class
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Janus kinase inhibitors in dermatology: A systematic review
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Characteristic features of Japanese women's hair with aging and with progressing hair loss
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Epidermal Stem Cells do not Communicate Through Gap Junctions
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- JAK Inhibitors for Treatment of Alopecia Areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Phenotypic Diversity and Mutation Spectrum in Hypotrichosis with Juvenile Macular Dystrophy
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Esrp1-Regulated Splicing of Arhgef11 Isoforms Is Required for Epithelial Tight Junction Integrity
- Phototrichogram Analysis of Japanese Female Subjects with Chronic Diffuse Hair Loss
- Alopecia as a rare but distinct manifestation of pemphigus vulgaris